Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands

INTRODUCTION: The progression-free survival of patients with HER2-positive metastatic breast cancer is significantly extended by a combination of two monoclonal antibodies, trastuzumab and pertuzumab, which target independent epitopes of the extracellular domain of HER2. The improved efficacy of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakefield, Devin L., Golfetto, Ottavia, Jorand, Raphael, Biswas, Sunetra, Meyer, Kassondra, Avery, Kendra N., Zer, Cindy, Cacao, Eliedonna E., Tobin, Steven J., Talisman, Ian J., Williams, John C., Jovanovic-Talisman, Tijana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149953/
https://www.ncbi.nlm.nih.gov/pubmed/37138747
http://dx.doi.org/10.3389/fmed.2023.1064242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149953/
https://www.ncbi.nlm.nih.gov/pubmed/37138747
http://dx.doi.org/10.3389/fmed.2023.1064242

Ejemplares similares